This seems likely to be of pathogenic significance, since, in rodent AD models, knockout or inhibition of neprilysin exacerbates the typical pathology and cognitive dysfunction, whereas measures which enhance neprilysin expression have an ameliorative impact in that regard [160,161,162]. The gene discussed is MME; the disease is Alzheimer disease.